Early hydroxyurea use is neuroprotective in children with sickle cell anemia.
Kristine A KarkoskaAmanda PfeifferDean W BeebeCharles T QuinnOmar NissPatrick T McGannPublished in: American journal of hematology (2022)
Children with sickle cell disease (SCD) who began hydroyxurea before age five years scored no differently on a measure of cognitive funciton than age, sex, and race-matched unaffected peers.